The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Deep learning–powered H&E whole-slide image analysis of endothelial cells to characterize tumor vascular environment and correlate treatment outcome to immunotherapy.
 
Seungeun Lee
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Jin Woo Oh
Employment - Lunit
 
Soohyun Hwang
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Jeanne Shen
No Relationships to Disclose
 
Sehhoon Park
Stock and Other Ownership Interests - Uppthera
Honoraria - AstraZeneca; Boehringer Ingelheim; Boryung; Bristol-Myers Squibb; Daiichi Sankyo; IMBdx; Merck; MSD; Roche; Takeda; Yuhan
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Boryung; Bristol-Myers Squibb; Daiichi Sankyo; IMBdx; Merck; MSD; Roche; Takeda; Yuhan
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Boryung; Bristol-Myers Squibb; Daiichi Sankyo; IMBdx; IQVIA; Merck; MSD; Roche; Takeda; Yuhan
Research Funding - Amgen; AstraZeneca; Merck; MSD; Yuhan
 
Hyojin Kim
No Relationships to Disclose
 
Young Kwang Chae
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Foundation Medicine; Guardant Health; Immuneoncia; Lilly; Lunit; Roche/Genentech; Takeda; Tempus
Speakers' Bureau - AstraZeneca; BMS; G1 Therapeutics; Genentech/Roche; Jazz Pharmaceuticals; Lilly; Merck
Research Funding - Abbvie; Biodesix; Bristol-Myers Squibb; Freenome; Lexent Bio
 
Se-Hoon Lee
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol Myers Squibb Foundation; Lilly; Merck Sharp & Dohme; Roche; Yuhan
Consulting or Advisory Role - Abion; AstraZeneca; BeiGene; BMS/Ono; Daiichi Sankyo; IMBdx; ImmuneOncia; Janssen; Lilly; Merck (German); Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Abion
Research Funding - AstraZeneca (Inst); Daiichi Sankyo; Lunit (Inst); Merck Sharp & Dohme (Inst)
 
Yoon-La Choi
Employment - abion (I)
Stock and Other Ownership Interests - abion (I)
Consulting or Advisory Role - LG Chem
Speakers' Bureau - J&J
 
Jin-haeng Chung
No Relationships to Disclose
 
Jaewoong Shin
Employment - Lunit
Stock and Other Ownership Interests - Lunit
Patents, Royalties, Other Intellectual Property - Lunit
 
Heon Song
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit
Patents, Royalties, Other Intellectual Property - Lunit
Other Relationship - Lunit
 
Aaron Valero Puche
Employment - Lunit
Stock and Other Ownership Interests - Lunit
Travel, Accommodations, Expenses - Lunit
 
Donggeun Yoo
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit
 
Taebum Lee
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Chiyoon Oum
Employment - Lunit
 
Jeongmi Kim
Employment - Lunit
 
Siraj Ali
Employment - EQRX; EQRX (I); lunit
Leadership - Droplet Biosciences; Elevation Oncology; Incysus; Pillar Biosciences; Promunity Tx
Stock and Other Ownership Interests - Exelixis; Merus NV; Pfizer; Pfizer
Consulting or Advisory Role - Nexo TX; SRone
Patents, Royalties, Other Intellectual Property - patents via FOundation Medicine; Patents via Seres Health on microbiome stuff in non neoplastic disease (I)
 
Chan-Young Ock
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit; Y-Biologics
Consulting or Advisory Role - De novo biotherapeutics; GCCELL; Genome & Company; Idience; Medpacto; PIN therapeutics; Selecxine; Y-Biologics